Heritable and spatial immunogenic traits co-predict the efficacy of immunotherapy in kidney cancer
- PMID: 38834849
- DOI: 10.1038/s41591-024-03020-8
Heritable and spatial immunogenic traits co-predict the efficacy of immunotherapy in kidney cancer
Similar articles
-
Cell fusion technology vaccine tested in kidney cancer clinical trial.Expert Rev Anticancer Ther. 2002 Dec;2(6):620. Expert Rev Anticancer Ther. 2002. PMID: 12503204 No abstract available.
-
Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes.Sci Immunol. 2020 Feb 21;5(44):eaaz3199. doi: 10.1126/sciimmunol.aaz3199. Sci Immunol. 2020. PMID: 32086382 Free PMC article.
-
[The present state and the future perspective of immunotherapy of renal cell carcinoma].Nihon Rinsho. 2015 Jan;73(1):167-74. Nihon Rinsho. 2015. PMID: 25626324 Review. Japanese.
-
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.Genome Med. 2020 Mar 30;12(1):32. doi: 10.1186/s13073-020-00731-8. Genome Med. 2020. PMID: 32228647 Free PMC article.
-
Renal cell cancer: is immunotherapy dead?Ann Oncol. 2007 Jul;18 Suppl 9:ix94-7. doi: 10.1093/annonc/mdm302. Ann Oncol. 2007. PMID: 17631604 Review. No abstract available.
Cited by
-
Trial watch: anticancer vaccination with dendritic cells.Oncoimmunology. 2024 Oct 9;13(1):2412876. doi: 10.1080/2162402X.2024.2412876. eCollection 2024. Oncoimmunology. 2024. PMID: 39398476 Free PMC article. Review.
References
-
- Saliby, R. M. et al. Update on biomarkers in renal cell carcinoma. Am. Soc. Clin. Oncol. Educ. Book 44, e430734 (2024). This comprehensive review article highlights the current state of the art on biomarkers in RCC.
-
- Saliby, R. M. et al. Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes. Cancer Cell 42, 732–735 (2024). This recent paper reports on various molecular subtypes in RCC and demonstrates the challenges of cross-study validation of current biomarkers for immunotherapy.
-
- Sprooten, J. et al. Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells. Cell Rep. Med. 5, 101377 (2024). This paper provides proof of concept for the use of reverse translation to reveal novel immunotherapy-resistance mechanisms and vaccine formulations relevant for T cell-depleted tumors. - DOI - PubMed - PMC
-
- Manczinger, M. et al. Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumor immunity. Nat. Cancer 2, 950–961 (2021). This paper reports the impact of specificity in the neo-antigen presentation of an HLA repertoire in the context of response to immunotherapy. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical